Brian M. Gallagher has joined Magen Biosciences as president and CEO.
John F. DeBernardis will resign as CEO of Applied NeuroSolutions.
Neuren Pharmaceuticals announced the appointment of Parmjot Bains, MD to the position of COO.
Proteome Sciences has named Peter Schulz-Knappe, MD as Research and Development Director/Chief Science Officer.
Michael Tansey, MD has joined La Jolla Pharmaceutical Company as Chief Medical Officer.
Biogen Idec has named Cecil B. Pickett President of R&D.
Charles Gluchowski, Ph.D., has been appointed as the Medicure's VP of R&D.
Octagon Research Solutions has appointed Doug Fulling as VP of Business Development.
AAIPharma announced today the appointment of Ninad Deshpanday, Ph.D. to the newly-created position of VP of Pharmaceutical Business Development.
Aileen Ryan has joined Vion Pharmaceuticals' management team as VP of Regulatory Affairs.
Jaime Davidson, MD, FACP, FACE, has been appointed Medical Director of Generex Biotechnology.
Merrimack Pharmaceuticals has added Louis Weiner, MD, to its Scientific Advisory Board.
Schering-Plough Corporation has named John M. Carroll VP, Global Internal Audits.
Acambis announces that, effective October 1, Alan Smith will retire as Chairman and will be succeeded by Peter Fellner, MD.
Former FEMA director Joe M. Allbaugh has joined Emergent BioSolutions board of directors.
Bristol-Myers Squibb has added Vicki L. Sato, Ph.D., to its board of directors.
Axm Pharma has named Steven M. Dinh to its board of directors.
Nascent Pharmaceuticals, Inc. announced today that Joanna C. Horobin, MD, has been appointed to its board of directors.
SpectraScience has elected Stanley Pappelbaum, MD to its board of directors.
Earl Collier has been named to the deCODE Genetics' board of directors.